ClinicalTrials.gov
public full text
Public Domain
Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects
To test pharmacodynamic response to clopidogrel 150mg once daily during 7 days in healthy subjects carriers of a mutated allele (\*2) associated with CYP2C19 deficiency and non responders to the usual regimen of 75 mg once daily
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-term comorbidities and mortality associations with treatment in generalized pustular psoriasis: a multi-institutional cohort study.#988486
- TREC - Evaluation of the Impact of Eversion Technical Features on the Rate of Carotid Restenosis#249519
- DP18595: Harnessing Genetic Variants for Local Average Treatment Effect Estimation#147736
- Pharmacogenetic Variation and Its Clinical Relevance in a Latin American Rural Population#948559
- Amerindian ancestry influences genetic susceptibility to chronic obstructive pulmonary disease#948922
Record · ID 811449
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive